Addex Therapeutics (ADXN) Financial Statements

82 Followers

Addex Therapeutics Financial Overview

Addex Therapeutics's market cap is currently $6.90M. The company's EPS TTM is $-7.1; its P/E ratio is -0.71; Addex Therapeutics is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Mar 24	Dec 22	Dec 21
Income Statement
Total Revenue	CHF 208.14K	CHF 404.10K	CHF 1.61M	CHF 1.42M	CHF 2.92M
Gross Profit	CHF 197.94K	CHF 404.10K	CHF 1.61M	CHF 1.42M	CHF 2.92M
Operating Income	CHF -3.39M	CHF -2.76M	CHF -2.24M	CHF -10.54M	CHF -15.51M
EBITDA	CHF -3.38M	CHF -4.65M	CHF -2.19M	CHF -10.45M	CHF -14.94M
Net Income	CHF -8.10M	CHF 7.06M	CHF -10.56M	CHF -20.80M	CHF -15.35M
Balance Sheet
Cash & Short-Term Investments	CHF 1.64M	CHF 3.35M	CHF 3.87M	CHF 6.96M	CHF 20.50M
Total Assets	CHF 6.37M	CHF 10.68M	CHF 4.64M	CHF 8.28M	CHF 22.54M
Total Debt	CHF 34.73K	CHF 41.99K	CHF 344.34K	CHF 373.13K	CHF 482.01K
Net Debt	CHF -1.61M	CHF -3.30M	CHF -3.52M	CHF -6.58M	CHF -20.00M
Total Liabilities	CHF 1.60M	CHF 1.00M	CHF 3.50M	CHF 3.37M	CHF 5.61M
Stockholders' Equity	CHF 4.77M	CHF 9.68M	CHF 1.15M	CHF 4.91M	CHF 16.93M
Cash Flow
Free Cash Flow	CHF -2.08M	CHF -5.37M	CHF -8.00M	CHF -16.44M	CHF -14.74M
Operating Cash Flow	CHF -2.08M	CHF -5.37M	CHF -7.99M	CHF -16.44M	CHF -14.71M
Investing Cash Flow	CHF -650.08K	CHF 4.65M	CHF -6.84K	CHF 2.97K	CHF -30.31K
Financing Cash Flow	CHF 1.13M	CHF 104.92K	CHF 5.26M	CHF 3.10M	CHF 16.40M

Currency in CHF

Addex Therapeutics Earnings and Revenue History

Income Statement >

Addex Therapeutics Debt to Assets

Balance Sheet >

Addex Therapeutics Cash Flow

Cash Flow >

Addex Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >